Dyslipidemia

The LIVMOR Halo AF Detection System has received 510(k) clearance from the US FDA and becomes the first prescriptible wearable for continuous heart monitoring in patients with atrial fibrillation.

Only 29.5% of sampled CBD users claimed any wellness benefit.

A Penn Medicine study found addition of prompts to an EHR did not significantly change the percentage of patients prescribed a statin.

This edition from the 10 Year Plan features perspective from leadership at ACC and ESC, as well as survey results from cardiologists.

These recommendations were developed with the primary goal of improving outcomes in cardiovascular mortality.

Chief member of Practical Cardiology's editorial advisory board discusses his approach to cholesterol education and the current state of cholesterol management in 2020.

A meta-analysis of more than 3 dozen RCTs suggests increased intake of omega-3 supplements, such as EPA and DHA, was linked to a decreased risk of myocardial infarction action and coronary heart disease events.

With September recognized as National Cholesterol Education Month, Dr. Weiss reflects on the importance of cholesterol management as part of mitigating risk of events in patients with ASCVD.